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Abstract
Background: Hyperlactataemia and metabolic acidosis are important risk factors for malaria death, but measuring
lactate at the point of care is not financially viable in many resource-poor settings. This study aimed to identify
combinations of routinely available parameters that could identify children at high risk of hyperlactataemia.
Methods: Using data from a study of Gambian children aged six months to 16 years with severe or uncomplicated
malaria, logistic regression modelling with a forward stepwise model selection process was used to develop a
predictive model for hyperlactataemia from routinely available demographic, clinical and laboratory parameters.
Potential predictors of hyperlactataemia considered for the modelling process were patient characteristics
(age, sex, prior use of anti-malarials, and weight percentile for age), respiratory symptoms (deep breathing, irregular
respiration, use of accessory muscles of respiration, lung crepitations, grunting respiration, cough, and age-specific
respiratory rate), other clinical parameters recorded at presentation (duration of symptoms, Blantyre coma score,
number of convulsions prior to admission, axillary temperature, dehydration, severe prostration, splenomegaly) and
laboratory measures from blood tests (percentage parasitaemia, white cell count, lymphocyte count, neutrophil
count, monocyte count, platelet count, haemoglobin level, blood glucose level).
Results: 495 children were included, and 68 (14%) had laboratory-confirmed hyperlactataemia (lactate > 7 mmol/L).
Four features were independently associated with increased hyperlactataemia risk in a multivariable age- and
sex-adjusted model: lower Blantyre score (odds ratio (OR) compared to score 5 = 2.68 (95% CI, 1.03-6.96) for score
3–4 and 6.18 (95% CI, 2.24-17.07) for score 0–2, p = 0.001), higher percentage parasitaemia (OR = 1.07 (1.03-1.11)
per 0031% increase, p < 0.001), high respiratory rate for age (OR = 3.09 (1.50-6.38) per unit increase, p = 0.002), and
deep breathing (OR = 2.81 (1.20-6.60), p = 0.02). Cross-validated predictions from the final model achieved area
under the receiver operating characteristic curve of 0.83.
Conclusions: This study identified predictors of hyperlactataemia requiring only simple bedside clinical
examination and blood film examination that can be carried out in resource-limited settings to quickly identify
children at risk of dangerously raised lactate. A simple spreadsheet tool implementing the final model is supplied
as supplementary material.
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Background
While Plasmodium falciparum malaria declines [1], the
proportion of cases with severe malaria may increase [2].
Low-cost tools for early identification of those at highest
risk of dying would allow tailoring of limited resources to
those who need them most. Metabolic acidosis is one of
the most frequent presentations defining severe malaria
[3], and is associated with a high risk of death in African
children with severe malaria, no matter whether it is cap-
tured as base excess [4,5], lactataemia [4,6-10], or by clin-
ical signs of respiratory distress, such as deep breathing or
lower chest wall in-drawing [4,7,11].
While deep breathing may reliably detect the most se-
vere acidosis [12] respiratory symptoms are not universal
among children with high lactate [13], and in one study,
identified only 51% of children with high lactate who
died [6], suggesting the usefulness of lactate measure-
ment at the point of care. However, the consumables for
lactate measurement devices are expensive and generally
unavailable in resource-poor settings [6,14]. It would,
therefore, be desirable to have more easily observed clin-
ical and laboratory features that could identify children
at risk of high lactate during a malaria episode.
There is mixed evidence regarding correlations of
non-respiratory factors that are associated with severe
respiratory distress in malaria [9,13,15], and fewer data
are available relating hyperlactataemia with combina-
tions of respiratory and non-respiratory clinical factors
alongside easily available laboratory measures in a mul-
tivariable framework.
The aims of this study were therefore to identify predic-
tors of hyperlactataemia among children with malaria,
from a range of clinical and laboratory parameters usually
available in relatively resource-poor primary health care
settings; to develop a multivariable predictive model that
could be used to assess risk for hyperlactataemia; and to
implement this in an easy-to-use risk prediction tool.
Methods
Study population
The dataset used for these analyses arose from a study into
the pathogenesis of severe malaria that was carried out
from 2005 to 2011 and enrolled uncomplicated and severe
malaria cases in Gambian children aged six months to
16 years [16,17]. Uncomplicated malaria was defined as a
history of fever within the previous 48 hours, >5,000 asex-
ual P. falciparum parasites/μL (or percentage parasitaemia
>0.1%), and no other known cause of fever. In addition to
the above, severe malaria required the presence of at least
one of the following criteria: haemoglobin (Hb) ≤6 g/dL,
blood glucose ≤2.2 mmol/L, repeated convulsions (≥three
in previous 24 hours), Blantyre coma score of ≤ two in the
absence of hypoglycaemia and persisting for at least two
hours, lactate concentration >7 mmol/L (hyperlactataemia),
difficulty in breathing (abnormalities in the age-specific re-
spiratory rate, lower chest wall in-drawing or deep breath-
ing), and severe prostration (i e, observed inability to drink
or suck in children ≤ six months of age or inability to sit un-
supported in those > six months). Cases residing within a
40-km radius south of Banjul and presenting to the health
facilities at the Medical Research Council (MRC) in Fajara,
the Royal Victoria Teaching Hospital (RVTH) in Banjul,
the Jammeh Foundation for Peace (JFP) Hospital in
Bundung and the health centre in Brikama were enrolled.
Appropriate informed consent was obtained in all cases
from parents or legal guardians. The study received ethics
approval from the London School of Hygiene and Tropical
Medicine ethics committee.
Outcome and potential explanatory variables
Lactate was measured from a finger-prick blood sample at
enrolment using Lactate Pro (Arkray). It was decided a
priori to use a cut-off of 7 mmol/L for hyperlactataemia in
preference over the WHO-recommended 5 mmol/L [3],
since the odds of death increase sharply above 7 mmol/L in
this study area [7], and mortality in the study cohort was
predominantly among children with lactate >7 mmol/L
[17]. Of note, there was insufficient power to directly inves-
tigate mortality itself as an outcome.
Potential predictors of hyperlactataemia considered for
the modelling process were patient characteristics (age, sex,
prior use of anti-malarials, and weight percentile for age,
derived with reference to Centers for Disease Control age-
and sex-stratified growth charts [18]), respiratory symptoms
(deep breathing, irregular respiration, use of accessory mus-
cles of respiration, lung crepitations, grunting respiration,
cough, and age-specific respiratory rate ratio, defined as re-
spiratory rate/age-specific median respiratory rate [19]),
other clinical parameters recorded at presentation (duration
of symptoms, Blantyre coma score, number of convulsions
prior to admission, axillary temperature, dehydration, se-
vere prostration, splenomegaly) and laboratory measures
from blood tests (percentage parasitaemia, white cell count,
lymphocyte count, neutrophil count, monocyte count,
platelet count, Hb level, blood glucose level). A broad list of
candidate variables was considered, which could plausibly
be associated either directly with lactate levels, or more
generally with malaria severity, on the basis that even vari-
ables not causally linked directly to plasma lactate could
provide associational information helping to predict risk of
high lactate.
Statistical methods
Descriptive statistics and preliminary modelling
Descriptive statistics were initially produced for each po-
tential predictor of hyperlactataemia, by hyperlactatae-
mia status and overall. Associations between potential
predictors and hyperlactataemia were then investigated
Bhaskaran et al. Malaria Journal 2013, 12:423 Page 2 of 11
http://www.malariajournal.com/content/12/1/423
through logistic regression modelling. It was decided a
priori to include age and sex in all models due to the
association of these variables with a wide range of health
parameters. Initial preliminary modelling was carried out to
examine potential non-linear relationships between con-
tinuous variables and hyperlactataemia risk, to examine the
usefulness of log-transforming blood count variables, and
to decide appropriate choice of categories for multi-
category variables. The process and the justification of these
decisions are described in detail in Additional file 1. In
summary, the preliminary modelling led to the inclusion of
age as a linear threshold term above age five years, due to a
lack of univariate association with hyperlactataemia at
younger ages; the inclusion of blood glucose level as a four-
category variable (≤2.2, 2.2-4.4, 4.4-8.3, >8.3 mmol/L) due
to an apparently non-linear association with hyperlactatae-
mia; and to the use of log-transformed versions of the total
white cell, lymphocyte, neutrophil, monocyte, and platelet
count variables. The remaining continuous variables (axil-
lary temperature, age-specific respiratory rate ratio, Hb,
percentage parasitaemia) showed no evidence against lin-
earity, so were included in the modelling as simple linear
terms. Blantyre score was grouped into scores of 0–2, 3–4
and 5 due to low numbers of children with specific individ-
ual scores. History of convulsions was included as a simple
binary (yes/no) variable, and duration of symptoms was
included in three categories (≤one day, two, ≥three days).
Final model selection process
After carrying out the above-described preliminary ex-
ploratory analyses to decide on the optimal paramet-
rization of potential predictors of hyperlactataemia, a
forward stepwise model selection process was carried out
to decide on a final model. At each stage of the model
building, every variable was added in turn to the existing
model, and the variable with the lowest p-value (based on
a Wald test for that variable) was entered into the model
providing the p-value was <0.05. After the addition of a
new variable, any existing variable in the model no longer
significantly associated with the outcome (based on a
p-for-exit criterion of 0.10) was dropped (but had the
opportunity to re-enter the model in subsequent steps).
The model building was done in two stages due to missing
data in some variables. Initially, a model was developed re-
stricted to variables that were >90% complete in the data-
set, in order to avoid the loss of substantial numbers of
children from the analysis. The variables omitted from this
first stage were white cell, lymphocyte, neutrophil, mono-
cyte, platelet counts, and splenomegaly. However, a sec-
ond forward stepwise stage of model building was then
carried out among children with complete data on all
variables, beginning with the model developed in the first
stage, and testing each of the omitted variables for inclu-
sion using the same process as described above.
Model validity
The predictive performance and validity of the final
model were examined using leave-one-out cross-
validation, a process that avoids testing the predictive
performance of the model using the same data that were
used to estimate the model, which could lead to over-
optimistic results [20]. Having generated a set of predic-
tions a receiver operating characteristic (ROC) curve
was constructed, relating the sensitivity and specificity
of the model to the choice of probability cut-off used to
define a prediction of hyperlactataemia.
Sensitivity analysis
To examine sensitivity to the choice of model selection
strategy, the model selection was repeated using a back-
ward stepwise instead of forward stepwise process. The
model selection procedure was also re-run using the
WHO cut-off for hyperlactataemia (>5 mmol/L), to
understand whether different predictors would apply
when using this definition of hyperlactataemia.
Results
Description of study population
Out of a total of 495 children, 68 (14%) had hyperlactatae-
mia, defined as lactate >7 mmol/L. A total of 10 children
were known to have died, 8 (12%) in the hyperlactataemia
group, and 2 (0.5%) in the non-hyperlactataemia group.
The distribution of severe manifestations (hyperlactatae-
mia, severe anaemia, cerebral malaria) is shown by Venn
diagram in Additional file 1. The median age of children
was five years (IQR 3.3-9.0, Table 1). Children with hyper-
lactataemia had higher rates of prior anti-malarial use,
higher prevalence of respiratory symptoms, impaired con-
sciousness (Blantyre score <5), and severe prostration.
There were also apparent differences in laboratory param-
eters between children with and without hyperlactataemia
(Table 2): children with hyperlactataemia had higher me-
dian percentage parasitaemia (13.9 vs 5.0), lower median
platelet counts (55.5 vs 104.0 × 109/L), and lower median
Hb levels (8.7 vs 10.8 g/dL).
Age/sex-adjusted associations of individual variables with
hyperlactataemia
The analysis was initially restricted to variables that
were >90% complete in the dataset, resulting in 407
children being included in the first phase of modelling.
In logistic models for hyperlactataemia, adjusted only for
age and sex, deep breathing, use of accessory muscles,
grunting respiration, higher age-specific respiratory rate
ratio, shorter duration of symptoms, lower Blantyre coma
score, history of convulsions, severe prostration, higher
parasitaemia and lower Hb were all strongly associated
with higher risk of hyperlactataemia (Table 3). Blood glu-
cose was also strongly associated with hyperlactataemia
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Table 1 Characteristics of study participants, overall and by hyperlactataemia status
Characteristics of subjects Hyperlactataemia
(blood lactate >7 mmol/L)
No hyperlactataemia
(blood lactate ≤7 mmol/L)
Study population
Cell contents below are n (%) unless otherwise stated
Total N 68 (100.0) 427 (100.0) 495 (100.0)
Patient characteristics
Age in years
<1 0 (0.0) 3 (0.7) 3 (0.6)
1-4 40 (58.8) 170 (39.8) 210 (42.4)
≥ 5 28 (41.2) 254 (59.5) 282 (57.0)
Median (IQR) 4.0 (3.0 to 6.0) 5.0 (3.3 to 9.0) 5.0 (3.0 to 8.0)
Range 1.0 to 15.0 0.7 to 16.0 0.7 to 16.0
Sex
Male 30 (44.1) 238 (55.7) 268 (54.1)
Female 27 (39.7) 177 (41.5) 204 (41.2)
Missing 11 (16.2) 12 (2.8) 23 (4.6)
Weight %ile for age
<10 40 (58.8) 231 (54.1) 271 (54.7)
10-24 12 (17.6) 72 (16.9) 84 (17.0)
25-50 6 (8.8) 75 (17.6) 81 (16.4)
50-74 6 (8.8) 28 (6.6) 34 (6.9)
75-89 3 (4.4) 13 (3.0) 16 (3.2)
≥90 1 (1.5) 7 (1.6) 8 (1.6)
Missing 0 (0.0) 1 (0.2) 1 (0.2)
Prior use of anti- malarial
Yes 24 (35.3) 91 (21.3) 115 (23.2)
No 39 (57.4) 315 (73.8) 354 (71.5)
Missing 5 (7.4) 21 (4.9) 26 (5.3)
Respiratory symptoms*
Deep breathing 37 (54.4) 44 (10.3) 81 (16.4)
Irregular respiration 1 (1.5) 1 (0.2) 2 (0.4)
Use of accessory muscles 10 (14.7) 4 (0.9) 14 (2.8)
Lung crepitations 3 (4.4) 9 (2.1) 12 (2.4)
Grunting respiration 7 (10.3) 11 (2.6) 18 (3.6)
Cough 26 (38.2) 158 (37.0) 184 (37.2)
Age specific respiratory rate ratio (median, IQR) 2.3 (1.8 to 2.6) 1.7 (1.5 to 2.1) 1.8 (1.5 to 2.1)
Other clinical parameters
Duration of symptoms in days
≤ 1 10 (14.7) 34 (8.0) 44 (8.9)
2 35 (51.5) 139 (32.6) 174 (35.2)
3 14 (20.6) 156 (36.5) 170 (34.3)
≥ 4 9 (13.2) 98 (23.0) 107 (21.6)
Median (IQR) 1.0 (1.0 to 2.0) 2.0 (1.0 to 2.0) 2.0 (1.0 to 2.0)
Blantyre coma score
0-2 27 (39.7) 24 (5.6) 51 (10.3)
3-4 16 (23.5) 46 (10.8) 62 (12.5)
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risk, with the lowest risk among those with blood glucose
between 4.4 and 8.3 mmol/L, and higher risk at lower and
higher values.
Development of multivariate predictive model for
hyperlactataemia
The forward stepwise selection process, with age and sex
included as a priori (“forced”) variables, generated a final
model containing Blantyre score, percentage parasitaemia,
age-specific respiratory rate ratio, and presence of deep
breathing (Table 4). None of the variables omitted from
the first phase of modelling due to missing data were
added to the model in the second phase of modelling. The
area under the ROC curve for the final model was 0.85,
using the full dataset (see below for cross-validated model
performance statistics). In the final model, lower Blantyre
score, higher parasitaemia, higher age-specific respiratory
rate ratio, and deep breathing were all strongly associated
with increased probability of hyperlactataemia (Table 5). A
Microsoft Excel spreadsheet implementing the final model
to predict the probability of hyperlactataemia based on
these factors was produced (Additional file 2 - available as
web-only supplementary material - note that this spread-
sheet tool can also be opened in the open source spread-
sheet application OpenOffice Calc).
Model validation
Figure 1 shows the ROC curve and sensitivity/specificity
of the final predictive model. These curves were estimated
using leave-one-out cross validation to avoid assessing
model performance on the same data that were used to
generate the model. The area under the ROC curve was
0.83. Sensitivity and specificity naturally were dependent
on choice of the threshold value chosen. At the crossover
point (equal sensitivity and specificity), the sensitivity and
specificity met at a value of 76%.
Table 1 Characteristics of study participants, overall and by hyperlactataemia status (Continued)
5 24 (35.3) 357 (83.6) 381 (77.0)
Missing 1 (1.5) 0 (0.0) 1 (0.2)
Reduced reaction to pain**
Yes 22 (32.4) 18 (4.2) 40 (8.1)
No 46 (67.6) 409 (95.8) 455 (91.9)
History of Convulsions prior to admission
0 26 (38.2) 329 (77.0) 355 (71.7)
1 8 (11.8) 42 (9.8) 50 (10.1)
2 9 (13.2) 20 (4.7) 29 (5.9)
≥3 24 (35.3) 32 (7.5) 56 (11.3)
Missing 1 (1.5) 4 (0.9) 5 (1.0)
Temperature in °C
≤37 2 (2.9) 70 (16.4) 72 (14.5)
>37, ≤39 38 (55.9) 235 (55.0) 273 (55.2)
>39 28 (41.2) 122 (28.6) 150 (30.3)
Median (IQR) 38.8 (38.2 to 39.5) 38.4 (37.5 to 39.2) 38.5 (37.6 to 39.2)
Dehydration
Mild or Moderate 10 (14.7) 43 (10.1) 53 (10.7)
None 58 (85.3) 384 (89.9) 442 (89.3)
Severe prostration
Yes 54 (79.4) 146 (34.2) 200 (40.4)
No 14 (20.6) 279 (65.3) 293 (59.2)
Missing 0 (0.0) 2 (0.5) 2 (0.4)
Splenomegaly
Yes 11 (16.2) 74 (17.3) 85 (17.2)
No 51 (75.0) 302 (70.7) 353 (71.3)
Missing 6 (8.8) 51 (11.9) 57 (11.5)
*All listed respiratory symptoms data were complete, except for one child with missing cough status, and three children with missing respiratory rate (all in the no
hyperlactataemia group); age-specific respiratory rate ratio defined as (respiratory rate/median for age).
**Reduced reaction to pain defined as failure to localise pain (i e, flexes to pain or no response to pain).
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Sensitivity analysis
Using a backward rather than forward stepwise model
selection strategy produced a similar model but included
two extra terms, namely glucose category and Hb level. As
in the main analysis, the model also included Blantyre
score, percentage parasitaemia, age-specific respiratory
rate ratio, and deep breathing. The model appeared to per-
form similarly (cross-validated area under ROC curve =
0.82, compared with 0.83 for the model from the main
analysis). When the model selection procedure was re-run
using the WHO cut-off for hyperlactataemia (>5 mmol/L),
a slightly different set of parameters were selected (pros-
tration, percentage parasitaemia, Blantyre score, grunting,
and age-specific respiratory ratio) but a similar level of
predictive performance was achievable (cross-validated
area under ROC curve = 0.82).
Table 2 Laboratory parameters for study participants, overall and by hyperlactataemia status
Characteristics of subjects Hyperlactataemia
(blood lactate >7 mmol/L)
No hyperlactataemia
(blood lactate ≤7 mmol/L)
Study population
Cell contents below are n (%) unless otherwise stated
Total N 68 (100.0) 427 (100.0) 495 (100.0)
% parasitaemia
0-9 21 (30.9) 303 (71.0) 324 (65.5)
10-19 26 (38.2) 86 (20.1) 112 (22.6)
20-29 10 (14.7) 20 (4.7) 30 (6.1)
≥ 30 10 (14.7) 6 (1.4) 16 (3.2)
Missing 1 (1.5) 12 (2.8) 13 (2.6)
Median (IQR) 13.9 (7.1 to 25.0) 5.0 (2.0 to 10.0) 6.0 (2.0 to 12.4)
Total white blood cells (x109/L)
Median (IQR) 9.6 (7.0 to 13.5) 8.0 (6.1 to 10.8) 8.2 (6.2 to 11.3)
Missing [N(%)] 17 (25.0) 50 (11.7) 67 (13.5)
Total lymphocytes (x109/L)
Median (IQR) 2.7 (2.1 to 4.4) 2.0 (1.3 to 3.0) 2.1 (1.4 to 3.1)
Missing [N(%)] 17 (25.0) 62 (14.5) 79 (16.0)
Total neutrophils (x109/L)
Median (IQR) 5.5 (4.0 to 8.2) 5.1 (3.6 to 7.4) 5.2 (3.6 to 7.5)
Missing [N(%)] 17 (25.0) 116 (27.2) 133 (26.9)
Total monocytes (x106/L)
Median (IQR) 649.8 (466.1 to 1011.2) 525.3 (366.1 to 798.1) 537.4 (377.6 to 813.2)
Missing [N(%)] 18 (26.5) 115 (26.9) 133 (26.9)
Total platelets (x109/L)
Median (IQR) 55.5 (28.0 to 86.0) 104.0 (56.0 to 161.0) 95.0 (51.0 to 158.0)
Missing [N(%)] 18 (26.5) 40 (9.4) 58 (11.7)
Hb (g/dL)
Median (IQR) 8.7 (6.3 to 10.5) 10.8 (8.9 to 12.2) 10.5 (8.7 to 12.1)
Missing [N(%)] 3 (4.4) 14 (3.3) 17 (3.4)
Blood glucose (mmol/L)
≤2.2 7 (10.3) 7 (1.6) 14 (2.8)
>2.2, ≤4.4 13 (19.1) 39 (9.1) 52 (10.5)
>4.4, ≤8.3 29 (42.6) 298 (69.8) 327 (66.1)
>8.3 18 (26.5) 80 (18.7) 98 (19.8)
Missing [N(%)] 1 (1.5) 3 (0.7) 4 (0.8)
Median (IQR) 6.8 (4.2 to 8.6) 6.5 (5.4 to 7.8) 6.5 (5.3 to 7.9)
Note: Missing values for full blood count parameters are in part explained by the fact that there was no facility to perform full blood counts for children enrolled
in the first year of the study (n = 31).
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Discussion
In a study of 495 Gambian children with uncomplicated
or severe malaria, four features were identified that
were independently associated with an increased risk of
hyperlactataemia in a multivariable age- and sex-adjusted
model: lower Blantyre score, higher percentage parasit-
aemia, high respiratory rate for age, and presence of deep
breathing. Cross-validated predictions from the final model
achieved area under the receiver operating characteristic
curve of 0.83, while the sensitivity and specificity curves
met at a value of 76%, though in practice, clinicians might
prioritize higher sensitivity at the expense of lower specifi-
city, given the potential implications of missing a diagnosis
of hyperlactataemia. The final model was implemented in a
simple spreadsheet that predicts risk of hyperlactataemia
given the above factors (available as supplementary online
material).
Each of the variables included in the final model are
plausible in the context of the pathophysiology and epi-
demiology of severe malaria. A higher respiratory rate and
deep breathing are both compensatory pathophysiologic
mechanisms for metabolic acidosis of which hyperlactatae-
mia is a major contributor, especially in children [21,22].
The association of lower Blanytre score (impaired con-
sciousness) with hyperlactataemia is consistent with the
observation that cerebral malaria and respiratory distress
often occur together [5,11]. This results in markedly in-
creased mortality [5,11], and is associated with particularly
high lactate levels [17], essentially indicating a major organ
dysfunction [22]. At high parasite burden, parasite glycoly-
sis contributes to hyperlactataemia and hypoglycaemia, in
addition to the major contribution from increased glucose
consumption, plus reduced gluconeogenesis in the human
host [21]. More broadly, the predictors identified all sug-
gest a more severe presentation of disease, so it is expected
that these would correlate with hyperlactataemia, which
also tends to feature in more severe cases [10,23].
There has been little work done to date on identifying
predictors of hyperlactataemia among children with mal-
aria. In line with the results of the present study, Mtove et
al. [6] found high parasitaemia, deep breathing (also in-
cluded in the main model from the present analysis),
hypoglycaemia and low Hb (terms that were included in
the model described in this paper when a backward step-
wise approach was performed) to be strongly associated
with lactate levels >5 mmol/L. Newton et al. investigated
whether a range of clinical and laboratory parameters pre-
dicted lactate levels (as a continuous measure) among chil-
dren in three hospitals in Malawi, Kenya and Ghana [13].
Although the authors found that deep and/or irregular
breathing, coma and hypoglycaemia were associated with
hyperlactataemia across all sites, the adjusted-R2 values
from multivariable models, including all candidate predic-
tors, did not exceed 0.42, and the authors commented that
the predictors they had identified were not able to reliably
identify children with hyperlactataemia or acidosis. In con-
trast the final model from the present study appears from
cross-validation to have comparatively strong predictive
Table 3 Age/sex-adjusted associations of each variable
with hyperlactataemia
Variable Odds ratio
and 95% CI
p-value*
Weight %ile for age 0.83
<10 1.00 (REF)
10-24 0.95 (0.42 to 2.14)
25-50 0.50 (0.19 to 1.37)
50-74 1.02 (0.32 to 3.22)
75-89 1.31 (0.26 to 6.44)
≥90 0.75 (0.09 to 6.33)
Prior use of anti-malarial 1.71 (0.88 to 3.30) 0.11
Deep breathing 8.46 (4.22 to 16.96) <0.001
Irregular breathing 5.94 (0.36 to 98.49) 0.21
Use of accessory muscles 11.51 (2.58 to 51.26) 0.001
Lung crepitations 2.48 (0.64 to 9.70) 0.19
Grunting respiration 4.78 (1.56 to 14.60) 0.006
Cough 1.02 (0.54 to 1.90) 0.96
Age-specific respiratory rate
ratio** (per unit increase)
5.24 (2.75 to 9.98) <0.001
Duration of symptoms (days) 0.003
≤1 1.00 (REF)
2 0.67 (0.28 to 1.62)
≥3 0.24 (0.09 to 0.63)
Blantyre coma score <0.001
5 1.00 (REF)
3-4 4.35 (1.83 to 10.35)
0-2 15.12 (6.42 to 35.62)
Any convulsions 5.36 (2.74 to 10.49) <0.001
Axillary temperature (per °C increase) 1.40 (1.03 to 1.92) 0.03
Dehydration 1.56 (0.67 to 3.62) 0.3
Severe prostration 5.67 (2.72 to 11.81) <0.001
Splenomegaly 0.86 (0.38 to 1.97) 0.72
% parasitaemia (per 1% increase) 1.09 (1.05 to 1.12) <0.001
Hb (per 1 g/dL increase) 0.78 (0.69 to 0.89) <0.001
Blood glucose (mmol/L) 0.003
≤2.2 1.00 (REF)
>2.2, ≤4.4 0.22 (0.05 to 1.04)
>4.4, ≤8.3 0.09 (0.02 to 0.37)
>8.3 0.17 (0.04 to 0.76)
*p-values are from Wald tests for each parameter in models adjusted only for
age (linear term for number of years since age five years) and sex.
**Age-specific respiratory rate ratio defined as (respiratory rate/median for age).
Note: models were fitted among the 407 children with non-missing data for all
the variables in the Table.
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performance. This may be explained by the different pa-
rametrizations of variables– for example, parasitaemia and
respiratory rate for age were used as continuous variables
here, in contrast with the binary hyperparasitaemia and
irregular breathing variables used by Newton et al.; alterna-
tively, it may be that in the different setting of that study,
and given the different characteristics of patients and
health care facilities, lactate was simply less strongly associ-
ated with other observed parameters than in the present
study, or that by Mtove et al. [6]. The inclusion of percent-
age parasitaemia in the final model presented here con-
trasts with a study in Uganda, in which prevalence of
respiratory distress was not found to differ across regions
with different average parasite loads [15]. However, this
ecological comparison may have missed individual-level as-
sociations; the authors also commented that there may
have been some misclassification between malaria with
respiratory distress and pneumonia. In the present study, a
relatively high cut-off of peripheral parasitaemia was used
for inclusion (which improves the specificity of diagnosis
of malaria) [24], and no evidence was found of bacterial
co-infection using specific PCR for the two most common
bacterial pathogens, Streptococcus pneumoniae and non-
typhoid Salmonella [25], therefore such misclassification is
unlikely to have been an important issue.
Historically, individual symptoms such as deep breath-
ing and other respiratory observations have been used as
surrogates or warning signals for hyperlactataemia and
acidosis, though a study by Crawley et al. suggesting four
distinct respiratory patterns in cerebral malaria suggested
a need for more training to identify telltale combinations
of respiratory signs [26]. In keeping with an earlier study
[13], a large proportion of children with measurable
hyperlactaemia in the present study did not have deep
breathing recorded (31/68, 46%), and only a single child
had irregular breathing. Other single-dimension predictors
were equally unhelpful – only 27/68 children with hyper-
lactataemia (40%) had diagnosed cerebral malaria. The
model makes better use of all the available information on
a particular child by combining information from a num-
ber of predictors, both respiratory and non-respiratory,
and so, for example, could flag up an increased risk of
hyperlactaemia in a child with high parasitaemia and/or a
reduced Blantyre score, but no respiratory symptoms,
where this risk might otherwise have been missed. The
spreadsheet tool provided alongside this paper demon-
strates that the model can be implemented easily in a clin-
ical situation with only basic computing facilities available,
though further validation work is recommended before
the model is put to broad use. Ultimately, it is hoped that
Table 4 Forward stepwise selection of predictive model for hyperlactataemia
Model p-value for
additional variable
Akaike
information criterion
Area under the receiver operating
characteristic (ROC) curve
Age + sex 291.6 0.6
Age + sex + Blantyre score 1.7 × 10-09 254 0.76
Age + sex + Blantyre score +% parasitaemia 8.2 × 10-06 236.1 0.83
Age + sex + Blantyre score +% parasitaemia + age-specific
respiratory rate ratio
5.0 × 10-04 225.6 0.84
Age + sex + Blantyre score +% parasitaemia + age-specific
respiratory rate ratio + deep breathing
0.018 222.2 0.85
Note: models were fitted among the 407 children with non-missing data for all the variables in the initial model selection process (see Methods).
Table 5 Final model for hyperlactataemia
Estimated OR and 95% CI p-value*
Age (per year above 5) 0.98 (0.83 to 1.15) 0.81
Male sex 1.43 (0.67 to 3.04) 0.35
Blantyre score 0.001
5 1.00 (REF)
3-4 2.68 (1.03 to 6.96)
0-2 6.18 (2.24 to 17.07)
% parasitaemia (per 1% increase) 1.07 (1.03 to 1.11) <0.001
Age-specific respiratory rate ratio (per unit increase) 3.09 (1.50 to 6.38) 0.002
Deep breathing 2.81 (1.20 to 6.60) 0.018
Note: the predicted odds of hyperlactataemia for an individual child based on the final model are as follows:
log odds of HL = −5.852724 - 0.0198901*(years since fifth birthday if aged < five years, 0 otherwise) + 0.3589414 (if male sex) + 0.9853369 (if Blantyre score is 3
or 4) + 1.821678 (if Blantyre score is 0, 1, or 2) + 0.0664418*(% parasitaemia) + 1.129665*(age-specific respiratory rate ratio) +1.033156 (if deep breathing
is present).
The predicted probability of HL is calculated as Pr(HL) = e(predicted log odds)/(1 + e(predicted log odds)).
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this model would allow the quick and easy identification
of children at risk of hyperlactataemia, enabling early
prioritization and treatment of such children and a con-
sequent reduction in the risk of severe complications
and death.
This study has a number of limitations. The sample size
was relatively small, so there may have been insufficient
power to detect relatively weak associations between candi-
date predictors and hyperlactataemia, and some variables
may have been omitted that could improve predictive per-
formance. That said, this apparent drawback may have led
to improved model parsimony since any variables omitted
for this reason are likely to have only weakly contributed to
predicting hyperlactataemia risk, and from a practical per-
spective there is a premium on parsimony since a predictive
tool requiring a large number of inputs would be difficult
to use. The data came from a single West African country
where malaria transmission is comparatively low [27].
Considering that the predominant clinical presentation of
severe malaria differs according to endemicity, other clinical
parameters maybe more suited to predict lactate in high
transmission areas. Due to the relatively small sample size,
there was insufficient power to directly model death as an
outcome; a worthwhile area of future research using larger
datasets would be to develop models relating clinical and
laboratory parameters similar to those included in the
present study to mortality risk.
How pronounced a symptom is at presentation is in part
determined by factors such as ease of access to medical
facilities. The model may thus not perform as well in other
Figure 1 Cross-validated receiver operating characteristic (ROC) curve for the final model, and sensitivity and specificity by predicted
probability cut-off.
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settings. A further issue is that validation of the predictive
model was carried out within the same Gambian setting
used to develop it. To reduce the problems associated with
this, leave-one-out cross validation was used so that at no
point was the model’s performance tested on a data point
used in the model fitting, which could have led to over-
optimistic results [20]. Nevertheless, until the model is
tested in a broader range of settings, which is to be
encouraged, there can only be limited confidence about its
generalizability.
Despite these limitations, the detailed data recorded for
the original study upon which this analysis was based
enabled associations between a broad range of clinical
and laboratory characteristics and measured lactate to be
assessed, with all variables measured objectively by trained
health care workers. Extensive preliminary modelling
was carried out to characterize associations between can-
didate predictors and hyperlactataemia, including allow-
ance for non-linearity; a systematic analytic strategy was
then employed, and the sensitivity of results to the choice
of model selection process was checked.
Conclusions
Hyperlactataemia is among the most important risk factors
for malaria death, but measuring lactate or metabolic acid-
osis requires the use of blood lactate machines or blood gas
analysers which are expensive and often beyond the finan-
cial reach of health facilities in resource-poor settings that
care for children with potentially life-threatening malaria.
The predictors of hyperlactataemia identified in this study
require only simple bedside clinical examination (Blantyre
coma score, respiratory rate and deep breathing) and blood
film examination for malaria parasites, both of which can
be easily carried out in a wide range of settings, and not
only by doctors but also community health workers. The
final predictive model was implemented in a spreadsheet to
produce a simple user-friendly risk prediction tool, which
could be used in clinical practice to quickly identify chil-
dren at risk of dangerously raised lactate and in need of fur-
ther investigations and treatment. It is recommended that
the model be tested and validated in a variety of settings to
confirm its utility.
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